Heart Failure

View the latest content related to this topic

News Conference News ESC 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

Critics were quick to point out that this small, short-term trial—mostly in patients with preserved EF—had no medical arm.

Shelley Wood

September 01, 2024

Slides

See all

Presentation NY Valves 2024

Interventional Approaches to Septal Reduction Therapy

Presenter: Srihari S. Naidu

June 07, 2024

Presentation NY Valves 2024

Is there Still a Role for Surgery in HCM?

Presenter: Hiroo Takayama

June 07, 2024

Presentation NY Valves 2024

Myosin Inhibitors and Novel Medical Therapies for HCM

Presenter: Mark V. Sherrid

June 07, 2024

Presentation NY Valves 2024

The SESAME Procedure for Obstructive HCM.

Presenter: Jaffar M. Khan

June 07, 2024

Presentation NY Valves 2024

A Clinical Approach to Genetics in Hypertrophic Cardiomyopathy

Presenter: Martin Maron

June 07, 2024

News

See all

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

By Michael O'Riordan

September 17, 2024

News Daily News

Subcutaneous Furosemide Enables HF Patients to Address Congestion at Home

By Caitlin E. Cox

September 16, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

By Caitlin E. Cox

September 03, 2024

News Conference News ESC 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

By Shelley Wood

September 01, 2024

News Conference News ESC 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

By Michael O'Riordan

September 01, 2024

New York Valves 2024

June 5

June 07, 2024

EuroPCR 2024

May 14

May 17, 2024

ACC 2024

April 6

April 08, 2024

Videos on This Topic

See all

Advertisement

Heart Failure

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

Slides

Interventional Approaches to Septal Reduction Therapy

Is there Still a Role for Surgery in HCM?

Myosin Inhibitors and Novel Medical Therapies for HCM

The SESAME Procedure for Obstructive HCM.

A Clinical Approach to Genetics in Hypertrophic Cardiomyopathy

News

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Subcutaneous Furosemide Enables HF Patients to Address Congestion at Home

TCTMD’s Top 10 Most Popular Stories for August 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

More on This Topic

Conference Coverage

New York Valves 2024

EuroPCR 2024

ACC 2024

Videos on This Topic

Advertisement

Heart Failure

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content